Business Context and Reporting Period
Company: United HealthCare Corporation (UnitedHealth Group Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 1995
Business Overview: The Company operates in the managed health care industry, divided into two primary lines of business: owned health plans (assuming underwriting risk) and managed health plans/specialty managed care services (administrative fees). The reporting period includes the impact of the January 1995 acquisition of GenCare Health Systems and the February 1995 acquisition of Group Sales of Puerto Rico. The results exclude the operations of Diversified Pharmaceutical Services, Inc., which was sold in May 1994.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Sep 30, 1995 |
Three Months Ended Sep 30, 1994 |
Nine Months Ended Sep 30, 1995 |
Nine Months Ended Sep 30, 1994 |
|---|---|---|---|---|
| Total Revenues | $1,215,536 | $956,834 | $3,477,316 | $2,799,855 |
| Net Earnings | $93,670 | $80,842 | $272,981 | $1,580,971* |
| Net Earnings (Excl. Extraordinary) | $93,670 | $80,842 | $272,981 | $203,896 |
| Earnings Per Share (Diluted) | $0.53 | $0.46 | $1.55 | $9.01* |
| EPS (Excl. Extraordinary) | $0.53 | $0.46 | $1.55 | $1.16 |
| Cash and Cash Equivalents | $1,307,531 | N/A | $1,307,531 | N/A |
| Total Assets | $3,896,871 | N/A | $3,896,871 | N/A |
| Operating Cash Flow (9mo) | N/A | N/A | $267,485 | $192,382 |
*1994 nine-month figures include a $1.38 billion extraordinary gain from the sale of Diversified Pharmaceutical Services, Inc.
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 27% for the quarter and 24% for the nine-month period compared to 1994. This growth was driven by strong enrollment gains and the inclusion of GenCare and Group Sales acquisitions, which accounted for approximately 37% of the revenue increase.
- Profitability: Net earnings (excluding extraordinary items) increased 16% for the quarter and 34% for the nine-month period compared to the same periods in 1994. The 1994 comparison is adjusted to exclude $35.9 million in merger costs associated with the Ramsay and Complete Health acquisitions.
- Expense Ratios: Total operating expenses as a percent of revenues increased slightly to 87.6% for the quarter (from 86.3% in 1994) and 87.4% for the nine-month period (from 86.8% in 1994). This was primarily due to higher medical costs relative to premiums in certain Medicaid programs.
- Medical Expense Ratio: For owned health plans, the medical expense ratio increased slightly to 80.1% for the quarter and 79.5% for the nine-month period, attributed to declines in Medicaid premium rates and strategic increases in provider reimbursements.
- Investment Portfolio: Cash and investments decreased from $2.77 billion at year-end 1994 to $2.59 billion at September 30, 1995, reflecting the $515.4 million cash purchase of GenCare, partially offset by operating cash flows.
Guidance, Outlook, and Risks
- MetraHealth Acquisition: On October 2, 1995, the Company acquired The MetraHealth Companies, Inc. for a total consideration of $1.59 billion ($1.09 billion cash and $500 million convertible preferred stock). The deal includes potential earn-outs of up to $350 million for 1995 results and up to $175 million annually for 1996 and 1997 based on combined net earnings targets.
- Restructuring Charges: Management expects a substantial restructuring charge related to the integration of MetraHealth, to be reported in the fourth quarter of 1995.
- Competition and Pricing: Competition for commercial enrollment has increased in certain markets. While the Company maintains a strategy of pricing based on anticipated costs, there is no assurance that recent enrollment growth trends will continue.
- Health Care Inflation: National health care cost inflation remains higher than general inflation. The Company utilizes risk-sharing arrangements and provider contracts to mitigate this, though recently acquired MetraHealth products not based on networks may introduce additional risk.
- Regulatory Environment: Government regulation of employee benefit plans and health care is changing and varies by jurisdiction. Future regulations could increase compliance costs or affect profitability.
- Accounting Standards: The Company plans to adopt SFAS No. 121 (Impairment of Long-Lived Assets) and SFAS No. 123 (Stock-Based Compensation) in 1996. Management currently believes these will not have a material impact on results.
Investor Verification Checklist
- MetraHealth Integration Costs: Verify the magnitude of the anticipated restructuring charge for Q4 1995 related to the MetraHealth merger.
- Earn-out Performance: Monitor MetraHealth's 1995 operating results to determine if the $350 million earn-out threshold is met.
- Medical Cost Trends: Track the medical expense ratio for owned health plans, specifically monitoring the impact of Medicaid rate declines and provider reimbursement strategies.
- Liquidity Position: Confirm the Company's ability to fund the MetraHealth cash portion and future earn-outs while maintaining working capital, given the recent decrease in cash and investments.
- Enrollment Growth Sustainability: Assess whether commercial enrollment growth can be sustained amidst increasing market competition and potential pricing pressures.